Cleared Traditional

K121266 - CARDIOSCOPE

K121266 is the FDA 510(k) clearance for CARDIOSCOPE by Pulsecor Limited. It is a Class 2 Cardiovascular device (product code DXN) cleared through the Traditional 510(k) pathway after a 229-day FDA review.

K121266 · Pulsecor Limited · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2012
Decision
229d
Days
Class 2
Risk

K121266 is an FDA 510(k) clearance for the CARDIOSCOPE. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Pulsecor Limited (Crofton, US). The FDA issued a Cleared decision on December 11, 2012 after a review of 229 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Pulsecor Limited devices

Submission Details

510(k) Number K121266 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 26, 2012
Decision Date December 11, 2012
Days to Decision 229 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
104d slower than avg
Panel avg: 125d · This submission: 229d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 501
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K121266.
NEXFIN MODEL 2
K122381 · Edwards Lifesciences, LLC · Apr 2013
APPS-HEALTH01
K122098 · Andon Health Co, Ltd. · Mar 2013
BP652N (HEM-6300-Z)
K123498 · Omron Healthcare, Inc. · Mar 2013
FULLY AUTOMATIC ELECTRONIC BLOOD PRESSURE MONITOR
K121372 · Andon Health Co, Ltd. · Sep 2012
HEM-7200-Z (BP742)
K121932 · Omron Healthcare, Inc. · Aug 2012
MICROLIFE WRIST WATCH BLOOD PREEURE MONITOR, BP3MO1-3P
K120430 · Microlife Intellectual Property GmbH · Aug 2012